Charité

The Charité – Universitätsmedizin Berlin (Charité – Berlin University of Medicine) is one of Europe’s largest university hospitals. On four campuses across Berlin, it encompasses more than 100 clinics and scientific institutes, organized in 17 different departments, 13 of which focus on patient care, while the remaining focus on research and teaching. The Charité has numerous Collaborative Research Centers of the German Research Foundation and is one of Germany’s most research-intensive medical institutions. Further, it is one of Berlins largest employers with more than 20,900 employees from 119 countries across the Charité group of companies. From 2012 to 2022, it was ranked by Focus as the best of over 1000 hospitals in Germany. In 2019 to 2022 Newsweek ranked the Charité as the 5th best hospital in the world, and the best in Europe. More than half of all German Nobel Prize winners in Physiology or Medicine, including Emil von Behring, Robert Koch and Paul Ehrlich, have worked at the Charité. In 2021, the Berlin Institute of Health (BIH) became the translational research unit of Charité, marking a change in the German university system by making the Charité the first university clinic which receive direct and annual financial support by the federal state of Germany.

Role of institution in the project

The Charité will contribute to defining, monitoring and updating a set of rules which will guide the participation. These rules will describe minimum contribution, quality standards, type of data and metadata among others. The Charité is involved in all workpackages but WP8 – Business and Sustainability model. The main contributions include engagement with Cancer Care professionals, patient associations and stakeholders, engagement and requirements analysis, legal and ethical compliance, as well as shaping the technical design and implementation of a federated learning and data analysis infrastructure and a Common Data Model and hyperontology for data interoperability.

PD Dr. Tobias Penzkofer

PD Dr. Tobias Penzkofer is a senior radiologist at the Department of Radiology at Charité Universitätsmedizin Berlin with a background of bioinformatics and computer science and particular interest in networked image analysis research. His main areas of expertise are oncological imaging, with a focus on to abdominal and urogenital tumors and the development, clinical value and explicability of artificial intelligence in oncological imaging.

Isabel Theresa Schobert

Dr. Schobert went to medical school and received her MD/PhD degree at Charité - Universitätsmedizin Berlin. Since 2020 she has been working as a resident doctor in the Department of Radiology at Charité. Dr. Schobert's research and clinical interest focuses on cancer imaging.

Dr. Madhuri Rudolph

Dr. Madhuri Rudolph is an attending physician with a specialization in Radology. She completed her medical studies at Charité university hospital in Berlin and wrote her dissertation in the field of Neuroembryology. After that, she pursued her residency at the Department of Radiology of Charité. Since 2022, Dr. Rudolph has been working as a consultant at the Department of Radiology of Charité. Her clinical research has a focus on urogenital imaging, particularly prostate MRI.

Sophia Schulze-Weddige

Sophia Schulze-Weddige is a researcher and PhD candidate at the Department of Radiology at Charité Universitätsmedizin Berlin. Her background is in Cognitive Science with a specialization in Machine Learning and Computer Vision. Her research is focused on artificial intelligence for cancer imaging.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.